468
Views
0
CrossRef citations to date
0
Altmetric
Nephrology

Influencing factors of hospitalization in maintenance haemodialysis outpatients after a diagnosis of COVID-19

, , , , , & show all
Article: 2286638 | Received 30 May 2023, Accepted 16 Nov 2023, Published online: 06 Dec 2023

References

  • Marian G, Luis ASC, Nicola M, et al. COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain. Kidney Int. 2020;98:1–6.
  • Gabriel S, Ana MM, Iuliana A, et al. Clinical features and outcome of maintenance hemodialysis patients with COVID-19 from a tertiary nephrology care center in Romania. Renal Failure. 2021;43:49–57.
  • Wen JB, Shun KF, Hua Z, et al. Clinical characteristics and short-term mortality of 102 hospitalized hemodialysis patients infected with SARS-COV-2 omicron BA.2.2.1 variant in shanghai, China. New Microbe New Infect. 2022;49:101058.
  • Ibernon M, Bueno I, Rodríguez-Farré N, et al. The impact of COVID-19 in hemodialysis patients: experience in a hospital dialysis unit. Hemodial Int. 2021;25(2):205–213. doi: 10.1111/hdi.12905.
  • Chen Y, Klein SL, Garibaldi BT, et al. Aging in COVID-19: vulnerability, immunity and intervention. Ageing Res Rev. 2021;65:101205. doi: 10.1016/j.arr.2020.101205.
  • Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242. doi: 10.1001/jama.2020.2648.
  • Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi: 10.1056/NEJMoa2001017.
  • Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775–1776. doi: 10.1001/jama.2020.4683.
  • Salje H, Tran Kiem C, Lefrancq N, et al. Estimating the burden of SARS-CoV-2 in France. Science. 2020;369(6500):208–211. doi: 10.1126/science.abc3517.
  • Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020;323(20):2052–2059. doi: 10.1001/jama.2020.6775.
  • Ma Y, Diao B, Xifeng LV, et al. Novel coronavirus disease in hemodialysis (HD) patients: report from one HD center in Wuhan, China. 2019; medRxivpre print. Available at: doi: 10.1101/2020.02.24.20027201.Accessed February 27, 2020.
  • Singh AK, Khunti K. COVID-19 and diabetes. Annu Rev Med. 2022;73(1):129–147. doi: 10.1146/annurev-med-042220-011857.
  • Cariou B, Hadjadj S, Wargny M, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020;63(8):1500–1515. doi: 10.1007/s00125-020-05180-x.
  • Shi Q, Zhang X, Jiang F, et al. Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective study. Diabetes Care. 2020;43(7):1382–1391. doi: 10.2337/dc20-0598.
  • Seiglie J, Platt J, Cromer SJ, et al. Diabetes as a risk factor for poor early outcomes in patients hospitalized with COVID-19. Diabetes Care. 2020;43(12):2938–2944. doi: 10.2337/dc20-1506.
  • Agarwal S, Schechter C, Southern W, et al. Preadmission diabetes-specific risk factors for mortality in hospitalized patients with diabetes and coronavirus disease 2019. Diabetes Care. 2020;43(10):2339–2344. doi: 10.2337/dc20-1543.
  • Singh AK, Gillies CL, Singh R, et al. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis. Diabetes Obes Metab. 2020;22(10):1915–1924. doi: 10.1111/dom.14124.
  • Kular D, Chis Ster I, Sarnowski A, et al. The characteristics, dynamics, and the risk of death in COVID-19 positive dialysis patients in London, UK. Kidney360. 2020;1(11):1226–1243. doi: 10.34067/KID.0004502020.
  • Fisher M, Yunes M, Mokrzycki MH, et al. Chronic hemodialysis patients hospitalized with COVID-19: short-term outcomes in the Bronx, New York. Kidney360. 2020;1(8):755–762. doi: 10.34067/KID.0003672020.
  • Wang F, Nie J, Wang H, et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis. 2020;221(11):1762–1769. doi: 10.1093/infdis/jiaa150.
  • Chen R, Sang L, Jiang M, et al. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020;146(1):89–100. doi: 10.1016/j.jaci.2020.05.003.
  • Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–768. doi: 10.1093/cid/ciaa248.
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3.
  • Du Y, Lu Z, Jin J, et al. Hematological characteristics of patients with novel coronavirus pneumonia in intensive care unit. Int Immunopharmacol. 2021;97:107697. doi: 10.1016/j.intimp.2021.107697.
  • Vacchi C, Meschiari M, Milic J, et al. COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion. Rheumatology (Oxford). 2020;59(12):e147–e150. doi: 10.1093/rheumatology/keaa581.
  • Zhang L, Feng X, Zhang D, et al. Deep vein thrombosis in hospitalized patients with COVID-19 in Wuhan, China: prevalence, risk factors, and outcome. Circulation. 2020;142(2):114–128. doi: 10.1161/CIRCULATIONAHA.120.046702.